Leukotriene C4 and dimethylphenylpiperazinium-induced responses in canine airway tracheal muscle contraction and fluid secretion.
Leukotrienes have been implicated as putative mediators in several air way diseases. In previous canine studies it was shown that leukotriene C4 (LTC4) enhanced fluid secretion over baseline values and this enhancement could be blocked by hexamethonium. This indicates that leukotrienes have as one of their actions, stimulation of ganglionic motor neurons. In the present study, we determined that LTC4 acts at a similar site as the specific nicotinic receptor agonist dimethylphenylpiperazinium (DMPP). Both LTC4 and DMPP when given alone enhanced mucus secretion and induced tracheal muscle contraction over control baseline (p less than 0.05). When added to DMPP, LTC4 enhanced the DMPP effect of muscle contraction at 5 and 8 micrograms by a synergistic amount, while the secretion was only additive. The slopes of the dose-response curves for DMPP + LTC4 did not differ by a statistically significant amount. LTC4 and DMPP act on a similar, if not the same, ganglionic receptor.
D000818:Animals; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D009093:Mucus / Q000378:metabolism*; D009119:Muscle Contraction / Q000187:drug effects*; D010879:Piperazines / Q000494:pharmacology*; D013189:SRS-A / Q000494:pharmacology*; D013223:Statistics as Topic; D014132:Trachea / Q000378:metabolism / Q000502:physiology*
D010879:Piperazines; D013189:SRS-A; D004246:Dimethylphenylpiperazinium Iodide